I hope you're right but the value is worth what people will pay. CYDY and companies like them are a dime a dozen however I feel this one is a cut above.
It's like getting a Kentucky Derby horse. The odds are what they are...low. CYDY has enough info, backing and data to justify people finding value. True investors aren't getting scared of dilution or the bi-polar rants of Ben and Pears. Their buying would increase SP, which increasss shareholder value, which gets it off the pink sheets which brings more money.
None of that is happening. I'm long...don't confuse me for bashing. This drug is a decade or more in the making and we hang on every word and "sign" we get.
Right now it's worth $.53! I know that because I couldn't get $.54 for a block of shares today. That's the value.
I must say I feel the same way , imo we very undervalue , but that will not be important when the time is right. So , lets have good results , finish this 30 patients , and then imo , we go up...:))
Market Data 
Markets 
AI
